Azetidinecarboxamide derivatives for treating CNS disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 11, 2002
Grant Date -
N/A
app pub date -
Sep 17, 2001
filing date -
Jan 23, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
##STR1## A compound of formula (1), wherein: R.sup.1 is aryl; R.sup.2 is H, alkyl or aryl; and R.sup.3 is hydrogen or alkyl; pharmaceutically acceptable addition compounds thereof; and the use of the compounds in therapy, particularly for the treatment and prophylaxis of CNS disorders such as anxiety and epilepsy.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully